Literature DB >> 36033426

Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease.

Rachel Holmes1, Anahli Patel1, Archita P Desai1.   

Abstract

Content available: Audio Recording.
© 2022 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 36033426      PMCID： PMC9405520          DOI： 10.1002/cld.1204

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  23 in total

Review 1.  Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis.

Authors:  Emily Woltmann; Andrew Grogan-Kaylor; Brian Perron; Hebert Georges; Amy M Kilbourne; Mark S Bauer
Journal:  Am J Psychiatry       Date:  2012-08       Impact factor: 18.112

Review 2.  Psychiatric comorbidity in Wilson's disease.

Authors:  Gioia Mura; Paula C Zimbrean; Luigi Demelia; Mauro G Carta
Journal:  Int Rev Psychiatry       Date:  2017-07-06

3.  Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting- results from the German Hepatitis C-Registry (DHC-R).

Authors:  Valerie Ohlendorf; Arne Schäfer; Stefan Christensen; Renate Heyne; Uwe Naumann; Ralph Link; Christoph Herold; Willibold Schiffelholz; Rainer Günther; Markus Cornberg; Yvonne Serfert; Benjamin Maasoumy; Heiner Wedemeyer; Michael R Kraus
Journal:  J Viral Hepat       Date:  2021-05-18       Impact factor: 3.728

4.  Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C.

Authors:  Ali A Weinstein; Jillian Kallman Price; Maria Stepanova; Laura W Poms; Yun Fang; Juhi Moon; Fatema Nader; Zobair M Younossi
Journal:  Psychosomatics       Date:  2011 Mar-Apr       Impact factor: 2.386

5.  Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.

Authors:  Karen E Stewart; Deborah L Haller; Carol Sargeant; James L Levenson; Puneet Puri; Arun J Sanyal
Journal:  Liver Int       Date:  2014-03-10       Impact factor: 5.828

6.  Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.

Authors:  Carmine Rossi; Zahid A Butt; Stanley Wong; Jane A Buxton; Nazrul Islam; Amanda Yu; Maryam Darvishian; Mark Gilbert; Jason Wong; Nuria Chapinal; Mawuena Binka; Maria Alvarez; Mark W Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  J Hepatol       Date:  2018-08-22       Impact factor: 25.083

7.  Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.

Authors:  Matthew J Akiyama; Daniel Lipsey; Moonseong Heo; Linda Agyemang; Brianna L Norton; Jennifer Hidalgo; Kiara Lora; Alain H Litwin
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

8.  Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.

Authors:  Miriam K Depping; Natalie Uhlenbusch; Martin Härter; Christoph Schramm; Bernd Löwe
Journal:  JAMA Psychiatry       Date:  2021-06-01       Impact factor: 21.596

9.  A Behavioral Health Program for Alcohol Use Disorder, Substance Abuse, and Depression in Chronic Liver Disease.

Authors:  Manisha Verma; Jay Horrow; Victor Navarro
Journal:  Hepatol Commun       Date:  2019-03-12

Review 10.  Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review.

Authors:  Shao-Cheng Wang; Yuan-Chuan Chen; Shaw-Ji Chen; Chun-Hung Lee; Ching-Ming Cheng
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.